Medical Science Liaison - Autoimmune T1D

4w1 month ago

Sanofi

São Paulo, BR · Full-time · BRL 180,000 – BRL 250,000

About this role

Sanofi is seeking a Medical Science Liaison specializing in Autoimmune Type 1 Diabetes to drive scientific exchange and strategic initiatives in São Paulo. This role focuses on a first-in-class therapy that delays the onset of stage 3 T1D, offering new hope for at-risk individuals.

As the trusted scientific partner for external experts, you will engage with endocrinologists, pediatricians, and key opinion leaders on disease stages, screening importance, and treatment approaches. You will also collaborate on developing evidence-based screening and monitoring protocols adapted to local contexts.

You will work within the General Medicines division, partnering with cross-functional teams to improve patient pathways and remove barriers to early intervention. This agile environment supports personalized omnichannel engagement strategies and field insights that inform medical strategy.

This role offers the opportunity to shape a new paradigm in autoimmune diabetes care while contributing to Sanofi's R&D-driven, AI-powered mission. You will help transform healthcare delivery for chronic and specialty conditions worldwide.

Requirements

Advanced degree in life sciences, pharmacy, or medicine (MD, PhD, PharmD preferred)
Deep knowledge of Type 1 Diabetes disease landscape and immunomodulatory therapies
Experience engaging with KOLs and healthcare professionals in a scientific liaison capacity
Ability to translate complex scientific data into actionable insights for diverse audiences
Strong understanding of clinical research methodologies and regulatory frameworks
Proven ability to work in agile, cross-functional team environments
Fluency in Portuguese and English, with excellent presentation and writing skills

Responsibilities

Act as trusted scientific partner to external experts including KOLs, endocrinologists, and pediatricians
Conduct scientific exchange on T1D disease stages, screening importance, and treatment approaches
Collaborate on development of evidence-based screening and monitoring protocols
Adapt global screening strategies to local contexts and engage experts to promote best practices
Partner with cross-functional teams to improve patient pathways and remove barriers to care
Gather and analyze field insights to inform medical strategy and support Market Access teams
Coordinate requests for Investigator-Initiated Studies, RCTs, and Managed Access Programs
Stay current on medical and scientific developments in Type 1 Diabetes

Benefits

Opportunity to work on a first-in-class therapy delaying onset of stage 3 Type 1 Diabetes
Be part of an R&D-driven, AI-powered biopharma company with a deep understanding of the immune system
Collaborate with global experts and cross-functional teams in a dynamic, agile setting
Contribute to meaningful outcomes in diabetes, transplant, and immunology with the scale patients deserve